Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
| Autor: | Jones S, Holmes FA, O'Shaughnessy J, Blum JL, Vukelja SJ, McIntyre KJ, Pippen JE, Bordelon JH, Kirby RL, Sandbach J, Hyman WJ, Richards DA, Mennel RG, Boehm KA, Meyer WG, Asmar L, Mackey D, Riedel S, Muss H, Savin MA |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 3/10/2009, Vol. 27 Issue 8, p1177-1183, 7p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|